Use of snps of mch-r for identifying genetic disorders in maintaining the normal body weight
CA 2458357 A1 · Owner: Hebebrand, Johannes · Inventors: Hebebrand, Johannes; Ziegler, Andreas; Wermter, Ann-Kathrin
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A process for identification of a human individuals disposition for a genetic disorder in maintaining this individuals body weight by detecting single nucleotide polymorphisms (SNPs) of the melanin-concentrating hormone receptor (MCH-R).
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 21, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 21, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 21, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.